Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Mao

Showing results (391-400 of 565) with videos related to

Pageof 57
Sort By:
Journal for Immunotherapy of Cancer|October 18, 2019
TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapyTae Heung Kang, Chih-Ping Mao, Young Seob Kim, et al.
Cancer Medicine|September 28, 2019
Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution studyCheng-Long Huang, Hong-Wen Tan, Rui Guo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2011
Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapyGuan-qun Zhou, Yan-Ping Mao, Lei Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 23, 2020
Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009Meirong Li, Mengmeng Lu, Yunhao Lai, et al.
Oral Oncology|April 14, 2020
Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysisSi-Qi Tang, Cheng Xu, Xiao-Shuai Wang, et al.
Medicine|August 8, 2015
The Evolution of and Risk Factors for Neck Muscle Atrophy and Weakness in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy: A Retrospective Study in an Endemic AreaLu-Lu Zhang, Yan-Ping Mao, Guan-Qun Zhou, et al.
Molecular Cancer|October 22, 2013
MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinomaNa Liu, Ning Jiang, Rui Guo, et al.
Biomaterials Science|November 24, 2018
Regenerating infected bone defects with osteocompatible microspheres possessing antibacterial activityPeng-Fei Wei, Zuo-Ying Yuan, Wei Jing, et al.
Plos One|July 23, 2013
Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapyGuan-Qun Zhou, Xiao-Li Yu, Mo Chen, et al.
Cancer Medicine|April 6, 2019
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy eraLing-Long Tang, Shao-Bo Liang, Cheng-Long Huang, et al.
Pageof 57

Showing results (391-400 of 565) with videos related to

Sort By:
Pageof 57
Journal for Immunotherapy of Cancer|October 18, 2019
TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapyTae Heung Kang, Chih-Ping Mao, Young Seob Kim, et al.
Cancer Medicine|September 28, 2019
Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution studyCheng-Long Huang, Hong-Wen Tan, Rui Guo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2011
Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapyGuan-qun Zhou, Yan-Ping Mao, Lei Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 23, 2020
Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009Meirong Li, Mengmeng Lu, Yunhao Lai, et al.
Oral Oncology|April 14, 2020
Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysisSi-Qi Tang, Cheng Xu, Xiao-Shuai Wang, et al.
Medicine|August 8, 2015
The Evolution of and Risk Factors for Neck Muscle Atrophy and Weakness in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy: A Retrospective Study in an Endemic AreaLu-Lu Zhang, Yan-Ping Mao, Guan-Qun Zhou, et al.
Molecular Cancer|October 22, 2013
MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinomaNa Liu, Ning Jiang, Rui Guo, et al.
Biomaterials Science|November 24, 2018
Regenerating infected bone defects with osteocompatible microspheres possessing antibacterial activityPeng-Fei Wei, Zuo-Ying Yuan, Wei Jing, et al.
Plos One|July 23, 2013
Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapyGuan-Qun Zhou, Xiao-Li Yu, Mo Chen, et al.
Cancer Medicine|April 6, 2019
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy eraLing-Long Tang, Shao-Bo Liang, Cheng-Long Huang, et al.
Pageof 57